Sale!

TP63 Gene Ankyloblepharon-Ectodermal Defects-Cleft Lippalate Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TP63 Gene Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) Syndrome genetic test is a specialized diagnostic procedure aimed at detecting mutations in the TP63 gene, which are associated with AEC syndrome. This condition is characterized by a spectrum of anomalies including ankyloblepharon (fusion of the eyelids), ectodermal defects (affecting the skin, hair, nails, and teeth), and cleft lip/palate, among others. The test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding clinical management.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the TP63 gene. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. Given the implications of the results for affected individuals and their families, the test represents a critical step in the management of AEC syndrome, offering insights that can significantly impact treatment decisions and genetic counseling.

Description

TP63 Gene Ankyloblepharon-ectodermal defects-cleft lippalate Genetic Test

Test Name: TP63 Gene Ankyloblepharon-ectodermal defects-cleft lippalate Genetic Test

Components: TP63 Gene Ankyloblepharon-ectodermal defects-cleft lippalate Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TP63 Gene Ankyloblepharon-ectodermal defects-cleft lip/palate NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene Ankyloblepharon-ectodermal defects-cleft lip/palate NGS Genetic DNA Test gene TP63

Test Details: The TP63 gene is associated with a condition called Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome. This syndrome is characterized by abnormalities in the development of the skin, hair, nails, teeth, and other structures derived from the ectoderm. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AEC syndrome, NGS can be used to identify mutations or variations in the TP63 gene that may be responsible for the condition. By analyzing the TP63 gene using NGS, healthcare professionals can determine if there are any mutations or variations in the gene that are associated with AEC syndrome. This information can be used for diagnosis, genetic counseling, and potentially for personalized treatment or management plans for individuals with AEC syndrome or those at risk of developing the condition.

Test Name	TP63 Gene Ankyloblepharon-ectodermal defects-cleft lippalate Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TP63 Gene Ankyloblepharon-ectodermal defects-cleft lip/palate NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene Ankyloblepharon-ectodermal defects-cleft lip/palate NGS Genetic DNA Test gene TP63
Test Details	The TP63 gene is associated with a condition called Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome. This syndrome is characterized by abnormalities in the development of the skin, hair, nails, teeth, and other structures derived from the ectoderm. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AEC syndrome, NGS can be used to identify mutations or variations in the TP63 gene that may be responsible for the condition. By analyzing the TP63 gene using NGS, healthcare professionals can determine if there are any mutations or variations in the gene that are associated with AEC syndrome. This information can be used for diagnosis, genetic counseling, and potentially for personalized treatment or management plans for individuals with AEC syndrome or those at risk of developing the condition.